CL2013003114A1 - Compounds derived from isoxazole or triazole, rory inhibitors; pharmaceutical composition that includes them; and its use in the treatment of dibbling and inflammatory, autoimmune, allergic diseases, among others. - Google Patents

Compounds derived from isoxazole or triazole, rory inhibitors; pharmaceutical composition that includes them; and its use in the treatment of dibbling and inflammatory, autoimmune, allergic diseases, among others.

Info

Publication number: CL2013003114A1
Authority: CL; Chile
Prior art keywords: dibbling; isoxazole; triazole; autoimmune; inflammatory
Prior art date: 2011-04-28

Application number

CL2013003114A

Other languages

Spanish (es)

Inventor

Takaki Maeba

Katsuya Maeda

Masayuki Kotoku

Kazuyuki Hirata

Noriyoshi Seki

Hiroshi Yamanaka

Takayuki Sakai

Shintaro Hirashima

Shingo Obika

Makoto Shiozaki

Masahiro Yokota

Original Assignee

Japan Tobacco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-04-28

Filing date

2013-10-28

Publication date

2014-03-28

2013-10-28 Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc

2014-03-28 Publication of CL2013003114A1 publication Critical patent/CL2013003114A1/en

Links

208000026935 allergic disease Diseases 0.000 title 1
230000001363 autoimmune Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
150000003852 triazoles Chemical class 0.000 title 1

CL2013003114A 2011-04-28 2013-10-28 Compounds derived from isoxazole or triazole, rory inhibitors; pharmaceutical composition that includes them; and its use in the treatment of dibbling and inflammatory, autoimmune, allergic diseases, among others. CL2013003114A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2011100331		2011-04-28
US201161482418P	2011-05-04	2011-05-04

Publications (1)

Publication Number	Publication Date
CL2013003114A1 true CL2013003114A1 (en)	2014-03-28

Family

ID=65657129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2013003114A CL2013003114A1 (en)	2011-04-28	2013-10-28	Compounds derived from isoxazole or triazole, rory inhibitors; pharmaceutical composition that includes them; and its use in the treatment of dibbling and inflammatory, autoimmune, allergic diseases, among others.

Country Status (1)

Country	Link
CL (1)	CL2013003114A1 (en)

2013
- 2013-10-28 CL CL2013003114A patent/CL2013003114A1/en unknown

Similar Documents

Publication	Publication Date	Title
CL2015000295A1 (en)	2015-04-24	Compounds derived from alkylpyrimidine; pharmaceutical composition that includes them; Use for the treatment of viral infections and other diseases.
CL2013003472A1 (en)	2014-08-18	Compounds derived from halogenoalkyl-1,3-oxazines substituted, inhibitors of bace1 and / or bace2; procurement procedure; pharmaceutical composition that includes them; its use in the treatment and / or prophylaxis of diseases such as diabetes, Alzheimer's, als, autoimmune inflammatory diseases, cancer, among others.
CO2017004525A2 (en)	2017-08-10	Ror-gamma inhibitory dihydropyrrolopyridines
BR112016020199A2 (en)	2017-08-15	Human plasma kallikrein inhibitor compound, pharmaceutical composition comprising said compound, kit and its use
CL2011000691A1 (en)	2011-07-29	Compounds derived from substituted nicotinamide; pharmaceutical composition that includes them; use for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases.
CL2013001338A1 (en)	2014-03-28	Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv.
CL2014002093A1 (en)	2014-11-21	Piperidinopyrimidine derivative compounds; pharmaceutical composition that includes them; Use in the treatment of viral infections.
DOP2017000109A (en)	2017-07-31	DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL AND ITS USES
MX2021009673A (en)	2021-09-08	ROR-GAMMA MODULATORS.
CL2013003019A1 (en)	2014-02-14	Compounds derived from benzothiazole; pharmaceutical composition that includes them; and its use in the treatment of hiv.
CL2013001654A1 (en)	2014-03-28	Compounds derived from 6-amino-2-phenylamino-1h-benzimidazol-5-carboxamide; pharmaceutical composition; and its use in the treatment and / or prevention of inflammatory diseases and / or associated conditions, in particular pain.
CL2013000603A1 (en)	2013-06-21	Compounds derived from quinoline and quinoxaline, pi3k inhibitors; pharmaceutical composition that includes them; and its use in the treatment of an inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nocicenoiceptive and ophthalmic disease.
CL2014003462A1 (en)	2015-02-27	Use of substituted aminotriazolopyridine compounds, in the treatment of inflammatory, autoimmune, proliferative, allergy, transplant rejection, among others; pharmaceutical composition that includes them; pharmaceutical combination.
CL2018000978A1 (en)	2018-08-24	Peptide macrocycles against acinetobacter baumannii
CL2016001231A1 (en)	2017-01-20	Autotaxin Inhibitor Compounds
CL2015001231A1 (en)	2015-08-28	Heterocyclic compounds substituted with amide; pharmaceutical composition; useful in the treatment of an inflammatory or autoimmune disease.
BR112015022625A2 (en)	2017-07-18	microarrays for therapeutic agent delivery and methods of use
CL2012003415A1 (en)	2013-08-09	Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
CL2014002873A1 (en)	2015-04-24	Compounds derived from pyrimidin-amine or triazin-amine, adn-pk inhibitors; pharmaceutical composition; and its use for the treatment of cancer.
CL2014002412A1 (en)	2015-03-06	Compounds derived from pyrido [4,3-d] pyrimidine, as mek inhibitors; pharmaceutical composition that includes them; and its use for the treatment of inflammatory diseases, infections, autoimmune disorders, metabolic diseases and malignant diseases, among others.
CL2014001956A1 (en)	2014-11-07	Compounds derived from amidine-substituted beta-lactams; method for its preparation; medicine that understands them; and its use for the treatment and / or prophylaxis of bacterial infections.
CL2012003745A1 (en)	2013-05-31	Compounds derived from aminopyrazoloquinazolines, as inhibitors against the phosphorylating activity of the igf-1 receptor located in cell membranes; pharmaceutical preparation that contains them; and its use in the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases.
CL2015001279A1 (en)	2015-06-26	Compounds derived from pyridine, urate transporter inhibitors urat 1; pharmaceutical composition that includes them; use for the treatment or prevention of diseases such as gout, hyperuricemia, hypertension, kidney diseases, among others.
CL2013002003A1 (en)	2013-12-06	Compounds derived from 1, 2, 4-triazolo [4,3-a] quinoxaline, inhibitors of pde2 and / or 10; pharmaceutical composition that includes them; pharmaceutical combination; and its use in the treatment of diseases of the CNS
MX382747B (en)	2025-03-11	OPTIONALLY CONFENSED HETEROCYCLYN SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES.